Disruptive technologies for effectively rehabilitating chronic ambulatory disabi...
Disruptive technologies for effectively rehabilitating chronic ambulatory disability
Worlwide, about 60 million people have some kind of difficulty in walking, which is related to some neurological disorder
(stroke, dementia, neuromuscular diseases, etc). Roughly 40 million of affected correspond to elders and the...
ver más
MARSI BIONICS
2.1 (i) la investigación y desarrollo de dispositivos robóticos y sus tecnologías asociadas que asistan al movimiento de humanos, animales o...
TRL
4-5
| 260K€
Fecha límite participación
Sin fecha límite de participación.
¿Tienes un proyecto y buscas un partner? Gracias a nuestro motor inteligente podemos recomendarte los mejores socios y ponerte en contacto con ellos. Te lo explicamos en este video
Proyectos interesantes
RTC2019-007350-1
Plataforma para rehabilitación neuromotora y cognitiva media...
984K€
Cerrado
PerPedes
PerPedes AI assisted therapy in stroke rehabilitation
71K€
Cerrado
PID2020-117361RB-C22
DISEÑO Y VALIDACION FUNCIONAL DE LA PLATAFORMA REHAB-IMMERSI...
94K€
Cerrado
REMAKE
REcovery of Motor functions After stroKE exploiting and enh...
100K€
Cerrado
Información proyecto MARSI
Duración del proyecto: 36 meses
Fecha Inicio: 2018-02-12
Fecha Fin: 2021-02-28
Líder del proyecto
MARSI BIONICS
2.1 (i) la investigación y desarrollo de dispositivos robóticos y sus tecnologías asociadas que asistan al movimiento de humanos, animales o...
TRL
4-5
| 260K€
Presupuesto del proyecto
2M€
Fecha límite de participación
Sin fecha límite de participación.
Descripción del proyecto
Worlwide, about 60 million people have some kind of difficulty in walking, which is related to some neurological disorder
(stroke, dementia, neuromuscular diseases, etc). Roughly 40 million of affected correspond to elders and the % is higher in
Europe. The remaining is the sum of physically disabled by cerebral palsy (14 million), neuromuscular diseases (4 million),
spinal cord injury (paraplegia and quadriplegia, 3 million) and spina bifida (3 million).
Neurological disorders affect the lower motor of the nervous system and share the progressive muscle weakness, which
lead to several walk disability, loss of autonomy and psychosocial consequences. Most therapeutic treatments are limited to
medicines and musculoskeletal rehabilitation programs, which are very expensive and limited to 15-30 min/week
rehabilitation sessions.
Active lifestyle is the most effective measure to restore the physical conditions. But the loss of muscle strength impedes the
ambulatory function. The need is for a device allowing them walking effortlessly and safely in the everyday life activities.
Based on our ARES technology, -the minimal functional unit providing synchronized joints-muscles mobility- Marsi Bionics
has developed powered orthoses for in-house rehabilitation of patients affected by muscle weakness disorders, showing a
product portfolio that covers the needs of a wide range of Neurological Disorders. Marsi products will be commercialized
under renting models allowing patients acquiring it for daily use. This technology will improve these patients life quality and
enlarge life expectancy by avoiding critical health complications of losing walking ability.
Marsi is strengthened by joining with a leading company in the current industrial market, ESCRIBANO. This alliance in the
frame of SME Phase 2 will speed up industrialization, overcome the certification barrier and minimize the time to market. As
a result, we expect to reach above 36M€ turnover in 2023 and 81 generated jobs.